Fifth year in a row: Vinge – Sweden M&A Legal Adviser of the Year
Vinge has won Mergermarket’s award Sweden M&A Legal Adviser of the Year.
NEWS
Administrative Court Judgment – Shareholders of private equity funds are taxed according to capital income
On 20 November 2018, the Stockholm Administrative Court decided that dividends to eleven persons who indirectly owned units in the private equity firms Valedo Fund I AB and Valedo Fund II AB, shall only be taxed in the capital income tax category.
PRESS RELEASE
Fifth year in a row: Vinge – Sweden M&A Legal Adviser of the Year
Vinge has won Mergermarket’s award Sweden M&A Legal Adviser of the Year.
NEWS
Insurance services in Sweden – a summary
Vinge’s insurance team has written a brief summary of some of the main features of the Swedish regulations affecting foreign insurers with existing or contemplated business activities in Sweden.
At Vinge you will meet many of Sweden’s most accomplished specialists within business law. We like to emphasize the first part of our expertise – business.
To share our knowledge and experience is an integrated part of our business. We assist our clients by navigating through complex legal questions, with a focus on building long term relations.
Vinge’s palette has many bold colours. We believe in a workplace where everyone’s individuality is allowed to flourish. A workplace where everyone can reach their full potential. Together we forge unique teams for our clients. Do you want to make a difference with us?
Vinge is advising Dole Food Company, Inc
Vinge is advising Dole Food Company, Inc., in connection with the sale of all of the shares in Saba Fresh Cuts AB and Saba Fresh Cuts Oy to BAMA International AS.
Vinge is advising Danica Pension, Livsforsikringsaktieselskab, part of Danske Bank Group, in connection with the sale of all of shares in Danica Pension Försäkringsaktiebolag (publ).
Danica Pension Försäkringsaktiebolag (publ) has approx. 60 employees, 150,000 personal customers and 15,000 business customers.
Vinge advises Xspray Pharma in connection with a directed share issue
The board of directors of Xspray Pharma AB (publ) has resolved on a directed new issue of shares, whereby Xspray Pharma will raise proceeds of approximately SEK 92 million, before issue costs.